Learning to make a difference for chILD: Value creation through network collaboration and team science.

Area of Science:

• Healthcare delivery
• Rare diseases
• Pediatric respiratory medicine

Background:

• Children's interstitial lung disease (chILD) presents significant healthcare challenges due to its rarity and complexity.
• Existing healthcare systems often struggle with inequalities in providing high-quality care for rare pediatric conditions.
• Collaboration across diverse boundaries is essential for effective rare disease management.

Purpose of the Study:

• To explore the benefits of social learning within rare disease clinical networks.
• To apply the value creation framework to understand how these networks generate and transfer value.
• To highlight the role of networks in improving diagnosis and management of chILD.

Main Methods:

• Narrative review of literature on rare disease clinical networks.
• Application of the value creation framework.
• Case study analysis of the Children's Interstitial Lung Disease Respiratory Network of Australia and New Zealand (chILDRANZ).

Main Results:

• Rare disease clinical networks facilitate multidisciplinary collaboration and peer learning.
• Social learning spaces, like chILDRANZ meetings, help manage diagnostic uncertainty and develop best practices.
• Value is generated, realized, and transferred through collaborative efforts within these networks.

Conclusions:

• Collaborative clinical networks are crucial for addressing rare disease healthcare disparities.
• Investment in and support for networks and virtual centers of excellence are internationally recommended.
• chILDRANZ exemplifies successful social learning and value creation in rare pediatric respiratory care.